Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vaxart Inc VXRT

Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its... see more

NDAQ:VXRT - Post Discussion

Vaxart Inc > VXRT Rise in Stock Price
View:
Post by thevisionary2k on Feb 10, 2021 5:11am

VXRT Rise in Stock Price

On February 2, 2021 and February 3, 2021, the New York Academy of Sciences held a global Symposium, “The Quest for a Covid-19 Vaccine.”

 

Dr. Antony Fauci, National Institute of Infectious Diseases and Dr. Moncef Slaoui, Operation Warp Speed, were the Key Note Speakers.

 

Only the leading companies and researchers in the world were invited to participate, such as, Pfizer, Moderna, Novavax and Vaxart. Dr. Sean Tucker, Founder and Chief Scientific Officer of Vaxart was an invited Speaker.

 

Dr. Orin Levine, Lead Vaccine Delivery, of the Gates Foundation, was also a speaker. Gates has an estimated net worth of $132 billion as of Jan. 2021, according to Bloomberg, while his foundation is investing heavily in Covid-19.

 

https://www.nyas.org/events/2021/webinar-the-quest-for-a-covid-19-vaccine/

 

On February 3, 2021, Vaxart issued a press release:

 

Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate

 

https://investors.vaxart.com/press-releases

 

VXRT share price is expected to increase by over 100 percent in 2021 from $9/share to $17/share - $20/share as per The Wall Street Journal.

 

https://www.wsj.com/market-data/quotes/VXRT/research-ratings

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities